LNSR - LENSAR, Inc.
IEX Last Trade
8.28
0 0%
Share volume: 340
Last Updated: Fri 27 Dec 2024 07:57:35 PM CET
Surgical and Medical Instrument Manufacturing :
-0.06%
PREVIOUS CLOSE
CHG
CHG%
$8.28
0.00
0.00%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-08 | 2022-11-09 | 2023-03-16 | 2023-05-15 | 2023-08-09 | 2023-11-09 | 2024-03-04 | 2024-05-09 | |
| Total revenue | 8.038 M | 7.748 M | 10.232 M | 8.252 M | 12.012 M | 9.795 M | 12.105 M | 10.588 M | |
| Cost of revenue | 3.146 M | 3.859 M | 3.750 M | 3.932 M | 5.251 M | 4.918 M | 6.956 M | 4.924 M | |
| Gross profit | 4.892 M | 3.889 M | 6.482 M | 4.320 M | 6.761 M | 4.877 M | 5.149 M | 5.664 M | |
| -20.50% | 66.68% | -33.35% | 56.50% | -27.87% | 5.58% | 10.00% | |||
| Operating expenses | 11.403 M | 7.696 M | 8.819 M | 8.405 M | 9.353 M | 6.644 M | 7.837 M | 8.240 M | |
| Selling general and admin | 7.569 M | 6.119 M | 7.204 M | 6.755 M | 7.854 M | 5.117 M | 6.374 M | 6.796 M | |
| Research and development | 3.834 M | 1.577 M | 1.615 M | 1.650 M | 1.499 M | 1.527 M | 1.463 M | 1.444 M | |
| Total expenses | 14.836 M | 11.831 M | 12.845 M | 12.613 M | 14.879 M | 11.835 M | 15.066 M | 13.438 M | |
| -20.25% | 8.57% | -1.81% | 17.97% | -20.46% | 27.30% | -10.81% | |||
| Operating income | -6.798 M | -4.083 M | -2.613 M | -4.361 M | -2.867 M | -2.040 M | -2.961 M | -2.850 M | |
| Ebit | -6.798 M | -4.083 M | -2.613 M | -4.361 M | -2.867 M | -2.040 M | -2.961 M | -2.850 M | |
| Pretax income | -6.759 M | -3.991 M | -2.490 M | -4.272 M | -8.753 M | 2.568 M | -3.926 M | -2.157 M | |
| -40.95% | -37.61% | 71.57% | 104.89% | -129.34% | -252.88% | -45.06% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | -6.759 M | -3.991 M | -2.490 M | -4.272 M | -8.753 M | 2.568 M | -3.926 M | -2.157 M | |
| 40.95% | 37.61% | -71.57% | -104.89% | 129.34% | -252.88% | 45.06% | |||
| Net income | -6.759 M | -3.991 M | -2.490 M | -4.272 M | -8.753 M | 2.568 M | -3.926 M | -2.157 M | |
| 40.95% | 37.61% | -71.57% | -104.89% | 129.34% | -252.88% | 45.06% |